1. Home
  2. DOYU vs MXCT Comparison

DOYU vs MXCT Comparison

Compare DOYU & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DouYu International Holdings Limited ADS

DOYU

DouYu International Holdings Limited ADS

HOLD

Current Price

$3.55

Market Cap

134.3M

Sector

Technology

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

SELL

Current Price

$1.45

Market Cap

136.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DOYU
MXCT
Founded
2014
1999
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.3M
136.2M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
DOYU
MXCT
Price
$3.55
$1.45
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
★ $4.78
$4.11
AVG Volume (30 Days)
28.8K
★ 1.1M
Earning Date
11-19-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.53
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.43
$0.64
52 Week High
$7.23
$1.81

Technical Indicators

Market Signals
Indicator
DOYU
MXCT
Relative Strength Index (RSI) 26.71 69.59
Support Level N/A $1.15
Resistance Level $4.90 $1.54
Average True Range (ATR) 0.21 0.07
MACD -0.05 0.05
Stochastic Oscillator 4.00 85.69

Price Performance

Historical Comparison
DOYU
MXCT

About DOYU DouYu International Holdings Limited ADS

DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company aims to build an integrated game-centric ecosystem of livestreaming, video, voice, graphic content, and other interactive and community features. The company operates the platform both on mobile apps and PC portals, through which users can enjoy immersive and interactive games and entertainment livestreaming, access a wide array of video and graphic content, and participate in community events and discussions.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: